Novartis' Daniel Vasella - CEO Pay

Daniel Vasella, Novartis CEO

Daniel Vasella- Novartis

Total Compensation: $15.5M

2006 Revenue: $38.1B
2007 Revenue: $39.8B
Change: 4.46%

Details: Vasella earned 17 million Swiss francs, or about $15.5M in 2007. That's down from 21 million francs in 2006, or $17.5 million -- a figure that some say places him among the highest-paid executives in Europe.

Novartis News:
Vasella touts Novartis' diversification
CEO: Novartis plans big restructuring
Cash-rich Novartis CEO mulls biotech buyouts

Novartis' Daniel Vasella - CEO Pay
Read more on

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.